These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4227918)

  • 1. Serum inhibition of plasmin and of plasminogen activation in thrombotic diseases.
    Tsitouris G; Stathopoulou R; Tsevrenis I
    J Atheroscler Res; 1967; 7(4):425-33. PubMed ID: 4227918
    [No Abstract]   [Full Text] [Related]  

  • 2. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci.
    Wang H; Lottenberg R; Boyle MD
    J Infect Dis; 1995 Jan; 171(1):85-92. PubMed ID: 7798686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of plasmin activation].
    Fujii S; Muramatsu M
    Saishin Igaku; 1966 Feb; 21(2):238-50. PubMed ID: 4226027
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of activator on the esterase activity of plasmin obtained by streptokinase].
    Potron G; Droulle-Bertignon C; Ledoyen MP
    C R Seances Soc Biol Fil; 1975; 169(4):1029-33. PubMed ID: 2372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conversion of streptokinase-plasminogen complex to SK-plasmin complex in the presence of fibrin or fibrinogen.
    Takada Y; Takada A
    Thromb Res; 1989 Apr; 54(2):133-9. PubMed ID: 2526391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the streptokinase gene prevents Streptococcus equisimilis H46A from acquiring cell-associated plasmin activity in the presence of plasminogen.
    Malke H; Mechold U; Gase K; Gerlach D
    FEMS Microbiol Lett; 1994 Feb; 116(1):107-12. PubMed ID: 8132150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH; Summaria L; Robbins KC
    Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-D-val-leu-lys-aminoisophthalic acid, dimethyl ester, is sensitive to streptokinase-activator not to plasmin.
    Ts'ao C; Galluzzo TS
    Am J Clin Pathol; 1981 Mar; 75(3):372-7. PubMed ID: 6452054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptokinase-plasmin(ogen) activator assays.
    Radek JT; Davidson DJ; Castellino FJ
    Methods Enzymol; 1993; 223():145-55. PubMed ID: 8271949
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of group A streptococci with human plasmin(ogen) under physiological conditions.
    D'Costa SS; Boyle MD
    Methods; 2000 Jun; 21(2):165-77. PubMed ID: 10816378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THERAPEUTIC FIBRINOLYSIS. II. STUDIES ON THE EFFICACY OF STREPTOKINASE AND ACTASE IN VIVO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():539-46. PubMed ID: 14233282
    [No Abstract]   [Full Text] [Related]  

  • 14. Streptokinase-dependent delayed activation of horse plasminogen.
    Marcum JA; Highsmith RF; Kline DL
    Biochim Biophys Acta; 1982 Dec; 709(1):19-27. PubMed ID: 6217838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of plasminogen in its immobilization].
    Kudinov SA; Eretskaia EV
    Ukr Biokhim Zh (1978); 1979; 51(4):340-4. PubMed ID: 157580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activity of plasma, serum, thrombin, and plasmin toward synthetic trypsin substrates.
    Szczeklik E; Orlowski M; Szczeklik A; Narczewska B
    Thromb Diath Haemorrh; 1968 Mar; 19(1):99-106. PubMed ID: 4231461
    [No Abstract]   [Full Text] [Related]  

  • 17. Simple, sensitive method for measuring plasmin and plasminogen activity in plasma.
    Uete T; Shimano N; Morikawa M
    Clin Chem; 1975 Oct; 21(11):1632-7. PubMed ID: 240516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
    J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli.
    Leytus SP; Bowles LK; Konisky J; Mangel WF
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1485-9. PubMed ID: 6453346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic mechanism of the activation of human plasminogen by streptokinase.
    Kosow DP
    Biochemistry; 1975 Oct; 14(20):4459-65. PubMed ID: 126078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.